“…Although initial methods to measure CDT were cumbersome and costly (Bean and Peter, 1993;Stibler et al, 1986;Xin et al, 1991), the advent of test kits (Anton and Bean, 1994;Anton et al, 2001;Helander, 1999;Sillanaukee et al, 1994;Simonsson et al, 1996;Stibler et al, 1991) to evaluate CDT levels allowed for more widespread use and investigation. Reports of the utility of CDT in various clinical populations generally have found it to be specific for alcohol use with its sensitivity varying with the setting in which it was used (Arndt et al, 1997;Bell et al, 1994;Fagerberg et al, 1994;Jaakkola et al, 1994;Koppel et al, 1996;Meerkerk et al, 1998;Sillanaukee et al, 1998;Spies et al, 1995). Whereas CDT appears to be more specific to alcohol use in patients with moderate liver disease (Bell et al, 1993;Cotton et al, 1998;Xin et al, 1992), it is now becoming clear that individuals with the most severe form of liver diseases may have elevated CDT levels despite little or no use of alcohol (DiMartini et al, 2001;Heinemann et al, 1998).…”